SOPH SOPHiA GENETICS S.A.
Healthcare$5.01+2.66%ClosedMarket Cap: $359.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.60
P/S
4.31
EV/EBITDA
-5.25
DCF Value
$-24.84
FCF Yield
-13.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.3%
Operating Margin
-88.4%
Net Margin
-99.7%
ROE
-140.6%
ROA
-51.6%
ROIC
-63.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $21.7M | 68.0% | $-17.3M | $-19.3M | $— | — |
| Q4 null | $21.7M | 67.7% | $-18.0M | $-19.2M | $— | — |
| FY null | $77.3M | 61.9% | $-70.9M | $-79.0M | $— | — |
| Q3 null | $19.5M | 66.3% | $-17.9M | $-20.0M | $— | — |
| Q2 null | $18.3M | 67.0% | $-18.6M | $-22.4M | $— | — |
| Q1 null | $17.8M | 68.7% | $-16.0M | $-17.4M | $— | — |
| Q4 null | $17.7M | 68.2% | $-17.4M | $-15.2M | $— | — |
| FY null | $65.2M | 67.4% | $-66.6M | $-62.5M | $— | — |
| Q3 null | $15.9M | 67.2% | $-15.4M | $-18.4M | $— | — |
| Q2 null | $15.8M | 68.2% | $-15.0M | $-15.2M | $— | — |
| Q1 null | $15.8M | 65.9% | $-18.8M | $-13.7M | $— | — |
| Q4 2023 | $17.0M | 69.8% | $-18.9M | $-24.1M | $-0.37 | — |